Vaseline
- Manufacturer
- Conopco Inc. d/b/a Unilever | Alberto-Culver USA Inc.
- Effective date
- 2012-10-02
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 3
- Source
- full-release
- Hydrated at
- 2026-05-31 22:33:12
Label at a glance#
ProductVaseline Lip Therapy Advanced Formula
Active ingredientpetrolatum
Label structure9 sections
Contacts and useful links#
Label contents#
Full prescribing information#
OTC - ACTIVE INGREDIENT SECTION
Active ingredient
WHITE PETROLATUM, USP (100%)
WHITE PETROLATUM, USP (100%)
OTC - PURPOSE SECTION
Purpose:
Skin Protectant
Skin Protectant
INDICATIONS & USAGE SECTION
Uses
▪ temporarily protects and helps relieve chapped or cracked skin and lips
▪ helps protect from the drying effects of wind and cold weather
▪ temporarily protects and helps relieve chapped or cracked skin and lips
▪ helps protect from the drying effects of wind and cold weather
WARNINGS SECTION
Warnings:
For External Use Only
For External Use Only
OTC - WHEN USING SECTION
When using this product do not get into eyes
OTC - ASK DOCTOR SECTION
See a doctor if condition lasts more than 7 days
OTC - DO NOT USE SECTION
Do not use on ▪deep or puncture wounds ▪animal bites ▪serious burns
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children. If swallowed get medical help or contact a Poison Control Center right away.
DOSAGE & ADMINISTRATION SECTION
Directions apply as needed
INACTIVE INGREDIENT SECTION
Inactive Ingredient Flavor
OTC - QUESTIONS SECTION
Questions? Call 1-800-457-7084
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
VLT 0.35 oz. PDP
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
VLT blister card
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 204754 | petrolatum 100 % Topical Jelly | PSN | 3 |
| 210871 | Vaseline 100 % Topical Ointment | PSN | 3 |
| 210871 | petrolatum 1 MG/MG Topical Ointment [Vaseline] | SBD | 3 |
| 204754 | petrolatum 1 MG/MG Topical Ointment | SCD | 3 |
| 204754 | petrolatum 100 % Topical Jelly | SY | 3 |
| 210871 | Vaseline 1 MG/MG Topical Ointment | SY | 3 |
| 210871 | Vaseline 100 % Topical Ointment | SY | 3 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 64942-0053-2 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-5b54-f424-e053-dadaa90a57ce | Vaseline Lip Therapy Advanced Formula |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 64942-0053-1 | VaselineLip Therapy Advanced Formula | 10 g in 1 TUBE | OINTMENT | 10 | 3 | |
| 64942-0053-2 | VaselineLip Therapy Advanced Formula | 1 in 1 BLISTER PACK | OINTMENT | 1 | 3 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 64942-0053 | VASELINE LIP THERAPY ADVANCED FORMULA (PETROLATUM) OINTMENT [CONOPCO INC. D/B/A UNILEVER] | 3 | Legacy NDC, 2 package rows | 20121005_c4e87f3a-5e3b-4c9b-a1cd-21e9b3b625e3.zip |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| petrolatum | ACTIVE INGREDIENT | 4T6H12BN9U | 3 | |
| petrolatum | ACTIVE MOIETY | 4T6H12BN9U | 3 |
Products#
Every source-derived product name is available through these pages.
- Vaseline Lip Therapy Advanced Formula
- Petrolatum
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 64942-0053 | 64942-0053-1, 64942-0053-2 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| petrolatum | 4T6H12BN9U | ACTIB |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| c22f300e-1305-4642-8472-087d5c67fc21 | c4e87f3a-5e3b-4c9b-a1cd-21e9b3b625e3 | 2012-10-02 | Warnings | c22f300e-1305-4642-8472-087d5c67fc21 c4e87f3a-5e3b-4c9b-a1cd-21e9b3b625e3 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.

